Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.02.24	Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
27.02.24	Has Novavax Just Solved Its Biggest Problem? (MotleyFool)
27.02.24	Ausblick: Novavax gewährt Anlegern Blick in die Bücher (finanzen.net)
22.02.24	What's Going On With Novavax Stock Today? (Benzinga)
22.02.24	Novavax, Gavi Settle Pending Arbitration Related To Vaccine Advance Purchase Agreement (RTTNews)
22.02.24	Better Bull Market Buy: Novavax vs. Pfizer (MotleyFool)
15.02.24	Where Will Novavax Be in 10 Years? (MotleyFool)
03.02.24	Better Recovery Story Buy: Novavax vs. Teladoc (MotleyFool)
01.02.24	Could Novavax Stock Help You Become a Millionaire? (MotleyFool)
29.01.24	1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell (MotleyFool)
28.01.24	1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell (MotleyFool)
28.01.24	Is It Too Late to Buy Novavax Stock? (MotleyFool)
27.01.24	Where Will Novavax Be in 5 Years? (MotleyFool)
18.12.23	Novavax Says Taiwan Grants EUA For Nuvaxovid XBB.1.5 Dispersion For Injection COVID-19 Vaccine (RTTNews)
18.12.23	Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan (PR Newswire)
05.12.23	Novavax's Updated COVID-19 Vaccine Now Authorized in Canada (PR Newswire)
28.11.23	WHO Grants EUL For Novavax's Updated Protein-based COVID-19 Vaccine (RTTNews)
28.11.23	Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization (PR Newswire)
17.11.23	Novavax Appoints John Trizzino To Take On Newly Created Role Of President And COO (RTTNews)
17.11.23	Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities (PR Newswire)
13.11.23	BioNTech-Konkurrent CureVac-Aktie gewinnt: CureVac kommt bei mRNA-Grippeimpfstoff voran (finanzen.ch) CureVac vermeldet Fortschritte bei mRNA-Grippeimfpstoff.» mehr
10.11.23	Novavax to Participate in Jefferies London Healthcare Conference (PR Newswire)
09.11.23	Novavax Slashes FY23 Total Revenue Outlook - Update (RTTNews)
09.11.23	Novavax Inc. Q3 Loss decreases, beats estimates (RTTNews)
09.11.23	Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
08.11.23	Ausblick: Novavax präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
02.11.23	Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023 (PR Newswire)
01.11.23	Novavax's Updated COVID-19 Vaccine Approved In EU (RTTNews)
31.10.23	Novavax's Updated COVID-19 Vaccine Now Approved in the EU (PR Newswire)
31.10.23	Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU (PR Newswire)
18.10.23	Novavax Gets Full Marketing Authorization Of Its Prototype COVID-19 Vaccine In The U.K. (RTTNews)
18.10.23	Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom (PR Newswire)
18.10.23	Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore (PR Newswire)
13.10.23	Novavax COVID-19 Non-mRNA Vaccines To Be Available At Major Retail Pharmacies (RTTNews)
13.10.23	Novavax COVID-19 Vaccine Doses Available at Major Retail Pharmacies Across the U.S. (PR Newswire)
11.10.23	Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023 (PR Newswire)
10.10.23	Novavax Launches Choose to Protect™ Campaign to Educate Public About Importance of Updated COVID Vaccination this Fall (PR Newswire)
04.10.23	Novavax's Updated COVID-19 Vaccine Authorized And Recommended For Use In U.S. (RTTNews)
03.10.23	Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. (PR Newswire)
08.09.23	Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
08.09.23	Novavax to Participate in Upcoming September Conferences (PR Newswire)
22.08.23	Novavax's Protein-based COVID Vaccine Induces Broadly Neutralizing Responses Against XBB Subvariants (RTTNews)
22.08.23	Novavax's Updated Protein-based XBB COVID Vaccine Induced Neutralizing Responses Against Emerging Subvariants, Including EG.5.1 and XBB.1.16.6 (PR Newswire)
08.08.23	Novavax Inc. Q2 Earnings Summary (RTTNews)
08.08.23	Pre-market Movers: MTAC, AYX, DDOG, IFF, CHGG… (RTTNews)
08.08.23	Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights (PR Newswire)
08.08.23	Ausblick: Novavax zieht Bilanz zum abgelaufenen Quartal (finanzen.net) Novavax wird am Dienstag die Kennzahlen zum abgelaufenen Jahresviertel vorstellen.» mehr

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

07:07		Ausblick: Johnson & Johnson vermeldet Zahlen zum jüngsten Quartal
20.01.25		Schwache Performance in Europa: STOXX 50 präsentiert sich zum Ende des Montagshandels leichter
20.01.25		Montagshandel in Zürich: SMI schlussendlich im Plus
20.01.25		Gute Stimmung in Zürich: SLI schlussendlich in Grün
20.01.25		Starker Wochentag in Frankfurt: DAX legt zum Ende des Montagshandels zu
20.01.25		LSE-Handel: FTSE 100 letztendlich mit grünem Vorzeichen
20.01.25		Zuversicht in Frankfurt: LUS-DAX verbucht zum Handelsende Gewinne

07:07

Ausblick: Johnson & Johnson vermeldet Zahlen zum jüngsten Quartal

20.01.25

Schwache Performance in Europa: STOXX 50 präsentiert sich zum Ende des Montagshandels leichter

20.01.25

Montagshandel in Zürich: SMI schlussendlich im Plus

20.01.25

Gute Stimmung in Zürich: SLI schlussendlich in Grün

20.01.25

Starker Wochentag in Frankfurt: DAX legt zum Ende des Montagshandels zu

20.01.25

LSE-Handel: FTSE 100 letztendlich mit grünem Vorzeichen

20.01.25

Zuversicht in Frankfurt: LUS-DAX verbucht zum Handelsende Gewinne

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Kuehne+Nagel Int	206.70	2.43 %	K V
UBS Group	31.75	1.99 %	K V
Lonza Grp	563.20	1.59 %	K V
Sika	227.20	1.16 %	K V
Alcon	77.98	1.01 %	K V
Swisscom	512.50	0.00 %	K V
Novartis	89.23	-0.10 %	K V
Swiss Re	135.60	-0.18 %	K V
Swiss Life Hldg	721.80	-0.50 %	K V
Zurich Insur Gr	530.40	-1.67 %	K V

Nachrichten zu Novavax Inc.

Aktien Top/Flop

Novavax Peer Group Nachrichten

Meistgelesene Nachrichten